Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$90.24 - $124.05 $1.14 Million - $1.56 Million
-12,590 Closed
0 $0
Q2 2021

Jul 22, 2021

SELL
$93.66 - $139.27 $222,910 - $331,462
-2,380 Reduced 15.9%
12,590 $1.57 Million
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $11,657 - $15,501
-100 Reduced 0.66%
14,970 $1.97 Million
Q4 2020

Feb 18, 2021

BUY
$99.61 - $142.12 $1.5 Million - $2.14 Million
15,070 New
15,070 $2 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.73B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bradley Mark J. Portfolio

Follow Bradley Mark J. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bradley Mark J., based on Form 13F filings with the SEC.

News

Stay updated on Bradley Mark J. with notifications on news.